Mark Bonyhadi

4.5k citations

44 papers · 3.8k indexed · 1 hit paper · h-index 27

Impact in

Virology top 0.5%
- HIV Research and Treatment
Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Virology 10
- HIV Research and Treatment 10
Immunology 27
- Immune Cell Function and Interaction 24
- T-cell and B-cell Immunology 19
- Immunotherapy and Immune Responses 13

Co-authors: Qizhi Tang Jeffrey A. Bluestone Hideto Kaneshima Mingying Bi Emma L. Masteller Kammi Henriksen Hugh O. McDevitt Erik B. Finger
Journals: Blood (6 papers)The Journal of Immunology (5 papers)The Journal of Experimental Medicine (3 papers)Nature (3 papers)Experimental Hematology (2 papers)
Partner nations: United States France Switzerland

In The Last Decade

Mark Bonyhadi

44 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes 2004 · 1.0k citations

Peers

Countries citing papers authored by Mark Bonyhadi

Since Specialization

Citations

This map shows the geographic impact of Mark Bonyhadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bonyhadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bonyhadi more than expected).

Fields of papers citing papers by Mark Bonyhadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bonyhadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bonyhadi. The network helps show where Mark Bonyhadi may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Bonyhadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Bonyhadi Line = papers co-authored together Mark Bonyhadi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regulatory T‐cell expansion and function do not account for the impaired alloreactivity of ex vivo‐expanded T cells Immunology ·Nicolas Montcuquet, C. Gocmen, Sylvain Perruche, Anne Duperrier, Mélanie Couturier, M. Jared Thomas, Mark Bonyhadi, Christophe Ferrand, Pierre Tiberghien, Éric Robinet	2008	2
2	Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio Cytotherapy ·C. Gocmen, Nicolas Montcuquet, Delphine Sauce, Mohsen Fotovati, Francisco González Vilaplana, Christophe Ferrand, Mark Bonyhadi, Pierre Tiberghien, Éric Robinet	2008	9
3	Cell Isolation and Expansion Using Dynabeads ® Advances in biochemical engineering, biotechnology ·Axl Neurauter, Mark Bonyhadi, 土木学会海洋開発委員会, 恭吉工藤, Erik Ruud, Stephanie A. Camacho, Tanja Aarvak	2007	94
4	Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice Experimental Hematology ·Bruno Nervi, Michael P. Rettig, Julie Ritchey, Hanlin L. Wang, Gerhard Bauer, Jon Walker, Mark Bonyhadi, Ronald Berenson, Julie L. Prior, David Piwnica‐Worms, Jan A. Nolta, John F. DiPersio	2007	52
5	Transcriptome of retrovirally transduced CD8+ lymphocytes: Influence of cell activation, transgene integration, and selection process Molecular Immunology ·Marina Deschamps, Éric Robinet, Mohsen Fotovati, P Mercier, Delphine Sauce, John De Vos, Nicolas Montcuquet, Mark Bonyhadi, Thierry Rème, Pierre Tiberghien, Christophe Ferrand	2007	7
6	Ex Vivo-Expanded CD4+CD25+ Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/Differentiation of Pathogenic T Cells The Journal of Immunology ·Aurélie Trenado, Muriel Sudres, Qizhi Tang, Sébastien Maury, Frédéric Charlotte, Sylvie Grégoire, Mark Bonyhadi, David Klatzmann, Benoı̂t L. Salomon, José L. Cohen	2006	120
7	Optimization of in vitro expansion of macaque CD4⁺ T cells using anti‐CD3 and co‐stimulation for autotransfusion therapy Journal of Medical Primatology ·Nattawat Onlamoon, Victor Daniel Francis Flick, Natalia Sandoval, Ann E. Mayne, Mark Bonyhadi, В.А. Иванов, J. Bruce Sundstrom, Pavel Boštík, Aftab A. Ansari, François Villinger	2006	15
8	Quantitative Assessment of Human T Lymphocytes in RAG2−/−γc−/− Mice: The Impact of Ex Vivo Manipulation on In Vivo Functionality Experimental Hematology ·Rozemarijn S. van Rijn, Elles Simonetti, Anton Hagenbeek, Mark Bonyhadi, Gert Storm, Anton C. Martens, Saskia B. Ebeling	2006	12
9	268. CD19-Targeted Normal and CLL Patient T Cells Expanded with Beads Can Eradicate Systemic Tumors In Vivo Molecular Therapy ·Алі Данладі, Renier J. Brentjens, Daniel Hollyman, Mark Bonyhadi, Michel Sadelain, Isabelle Rivière	2006	2
10	In Vitro Engagement of CD3 and CD28 Corrects T Cell Defects in Chronic Lymphocytic Leukemia The Journal of Immunology ·Mark Bonyhadi, Mark W. Frohlich, Angela L. Rasmussen, Christophe Ferrand, Laura S. Grosmaire, Éric Robinet, José F. Leis, Richard T. Maziarz, Pierre Tiberghien, Ronald Berenson	2005	31
11	In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation Clinical Immunology ·Karen Earle, Qizhi Tang, Xuyu Zhou, Weiping Liu, Shiying Zhu, Mark Bonyhadi, Jeffrey A. Bluestone	2005	155
12	Retrovirus-Mediated Gene Transfer in Human Primary T Lymphocytes Induces an Activation- and Transduction/Selection-Dependent TCR-B Variable Chain Repertoire Skewing of Gene-Modified Cells Stem Cells and Development ·I Gusti Ngurah Agung Kade Dwi Arsana, Delphine Sauce, Anne Duperrier, F.S. Kauark, Mark Bonyhadi, Sabine C. Kooijman, Klaus Kuehlcke, Patrick Hervé, Pierre Tiberghien, Éric Robinet, Christophe Ferrand	2004	17
13	Optimization of Human T-Cell Expansion Ex Vivo Using Magnetic Beads Conjugated with Anti-CD3 and Anti-CD28 Antibodies Journal of Immunotherapy ·D Kalamasz, S. Alice Long, Ruth Taniguchi, Jane H. Buckner, Ronald Berenson, Mark Bonyhadi	2004	90
14	Identification of HIV-1 Determinants for Replicationin Vivo Virology ·Lishan Su, Hideto Kaneshima, Mark Bonyhadi, Robert Lee, Zhaoyu Hui, Mario Sergio Fabián Vega, Bin Du, Linda Rabin, Beatrice H. Hahn, Ernest F. Terwilliger, J M McCune	1997	30
15	High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS Gene Therapy ·Ivan Plavec, Manju Agarwal, Christopher A. Ambrose, Marbin Pineda, Zhaoyu Hui, Sylvie Ricord, Hideo Matsuzaki, Sonia Escaich, Mark Bonyhadi, Ernst Böhnlein	1997	64
16	Development of a Human Thymic Organ Culture Model for the Study of HIV Pathogenesis AIDS Research and Human Retroviruses ·Mark Bonyhadi, Lishan Su, Zhaoyu Hui, J M McCune, Hideto Kaneshima	1995	41
17	HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo Immunity ·Lishan Su, Hideto Kaneshima, Mark Bonyhadi, David D Terrones Huamán, Daniel Kraft, Linda Rabin, Joseph M. McCune	1995	180
18	HIV induces thymus depletion in vivo Nature ·Mark Bonyhadi, Linda Rabin, David D Terrones Huamán, D. A. Brown, Jon C. Kosek, Joseph M. McCune, Hideto Kaneshima	1993	330
19	Delta is the Cx-gene product in the γ/δ antigen receptor of dendritic epidermal cells Nature ·Mark Bonyhadi, A Weiss, P W Tucker, Robert E. Tigelaar, James P. Allison	1987	73
20	Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines. The Journal of Experimental Medicine ·Tuba Yilmaz, Mark Bonyhadi, Ronald B. Herberman, Howard A. Young, Stephen Μ. Hedrick	1985	49

About Mark Bonyhadi

Mark Bonyhadi is a scholar working on Virology, Immunology, Oncology, Genetics and Genetics, having authored 44 papers that have together received 3.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (24 papers), T-cell and B-cell Immunology (19 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (13 papers), Virus-based gene therapy research (11 papers), HIV Research and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Virology (864 citations), Immunology (2.6k citations), Hematology (307 citations), Oncology (716 citations) and Genetics (700 citations). Mark Bonyhadi has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Qizhi Tang, Jeffrey A. Bluestone, Hideto Kaneshima, Mingying Bi, Emma L. Masteller, Kammi Henriksen, Hugh O. McDevitt, Erik B. Finger, Gregory L. Szot and Jianqin Ye. Their work appears in journals such as Blood, The Journal of Immunology, The Journal of Experimental Medicine, Nature and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact